BioCryst lands additional $3.5M in funding for yellow fever treatment tests
BioCryst Pharmaceuticals Inc. has been given an additional $3.5 million by the federal government to support clinical trials using one of the company’s signature drugs in the treatment of yellow fever.
Read More
